TSO3 forms wholly owned subsidiary to meet US customer requirements

TSO₃ Inc. (TSX: TOS) ("TSO₃" or the "Company") an innovator in sterilization technology for medical devices in healthcare settings, today announced the formation of a wholly owned subsidiary: TSO₃ Corporation, structured under the laws of the State of Delaware, and located in the State of South Carolina, USA. The new entity is being created to meet the demands of US customers for product, service and education.

"During the second quarter the Company focused a great deal of its energies in developing a formal commercialization process for the STERIZONE^® Sterilization System." stated R.M. (Ric) Rumble, President and CEO.

"Alone and together with our sales and service partner Getinge Infection Control, the Company has made great strides, which we believe will result in securing contract positions with the largest and leading Group Purchasing Organizations (GPO's) and Integrated Delivery Networks (IDN's). In addition, TSO₃ is ushering "scores" of quotes through their individual processes, many of which the Company expects to successfully close. As a result of these efforts, it became clear that it was time to execute our plans to open a US location focused on the education and ongoing service requirements of the US customers." explained Mr. Rumble. "While the foundation and technical expertise of the Company is and will remain in Quebec City, establishing a presence in the US, which represents 40% of the worldwide market, will allow us to more effectively reach out to and service this high opportunity market." concluded Mr. Rumble.

The Company has leased approximately 6,000 square feet of space in Myrtle Beach, South Carolina. The location will house US customer service, clinical education and also will act as a US warehouse and service depot. The new location is expected to open in August of this year in time to meet US customer requirements.

SOURCE TSO3 Inc.